Advertisement
UK markets open in 1 hour 24 minutes

  • NIKKEI 225

    37,636.37
    -823.71 (-2.14%)
     

  • HANG SENG

    17,258.06
    +56.79 (+0.33%)
     

  • CRUDE OIL

    82.93
    +0.12 (+0.14%)
     

  • GOLD FUTURES

    2,328.80
    -9.60 (-0.41%)
     

  • DOW

    38,460.92
    -42.77 (-0.11%)
     

  • Bitcoin GBP

    51,487.89
    -1,980.34 (-3.70%)
     

  • CMC Crypto 200

    1,387.26
    -36.84 (-2.59%)
     

  • NASDAQ Composite

    15,712.75
    +16.11 (+0.10%)
     

  • UK FTSE All Share

    4,374.06
    -4.69 (-0.11%)
     
Money:

The five essential pieces of financial paperwork you must never lose

Mislaying key documents can cause real headaches, so it’s worth tracking down these most commonly-lost bits of paperwork

Company News For June 1, 2018

Zacks Equity Research
Updated
Kinder Morgan (KMI) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

  • General Motors Co.’s GM shares jumped 12.9% after the company stated thatthe SoftBank Vision Fund plans to invest $2.25 billion in its self-driving unit

  • Dollar General Corp. DG plummeted 9.4% after reporting fiscal first-quarter 2018 earnings per share of $1.36, lagging the Zacks Consensus Estimate of $1.40

  • Dollar Tree Inc.’s DLTR shares plunged 14.3% after posting fiscal first quarter 2018 earnings of $1.19 per share, missing the Zacks Consensus Estimate of $1.23

  • Shares of Madrigal Pharmaceuticals Inc. MDGL surged 145% after the company reported an encouraging Phase 2 clinical trial update forits liver-directed, thyroid hormone receptor called MGL-3196


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
General Motors Company (GM) : Free Stock Analysis Report
 
Dollar Tree, Inc. (DLTR) : Free Stock Analysis Report
 
Dollar General Corporation (DG) : Free Stock Analysis Report
 
Madrigal Pharmaceuticals, Inc. (MDGL) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.